Literature DB >> 10101375

Methadone treatment by general practitioners in Amsterdam.

G van Brussel1.   

Abstract

In Amsterdam, a three-tiered program exists to deal with drug use and addiction. General practitioners form the backbone of the system, helping to deal with the majority of addicts, who are not criminals and many of whom desire to be free of addiction. Distinctions are made between drugs with "acceptable" and "unacceptable" risks, and between drug use and drug-related crime; patients who fall into the former categories are treated in a nonconfrontational, nonstigmatizing manner; such a system helps prevent the majority of patients from passing into unacceptable, criminalized categories. The overall program has demonstrated harm reduction both for patients and for the city of Amsterdam.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10101375      PMCID: PMC2359435     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


  2 in total

1.  Detection of HIV antibodies in saliva as a tool for epidemiological studies.

Authors:  R van den Akker; J A van den Hoek; W M van den Akker; H Kooy; E Vijge; G Roosendaal; R A Coutinho; A M van Loon
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

2.  Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam.

Authors:  J A van den Hoek; R A Coutinho; H J van Haastrecht; A W van Zadelhoff; J Goudsmit
Journal:  AIDS       Date:  1988-02       Impact factor: 4.177

  2 in total
  2 in total

1.  Addiction treatment: promoting a medical approach to substance use.

Authors:  G L Stein; A R Fleischman
Journal:  J Urban Health       Date:  1998-09       Impact factor: 3.671

2.  Physicians' attitudes towards office-based delivery of methadone maintenance therapy: results from a cross-sectional survey of Nova Scotia primary-care physicians.

Authors:  Jessica Dooley; Mark Asbridge; John Fraser; Susan Kirkland
Journal:  Harm Reduct J       Date:  2012-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.